126 related articles for article (PubMed ID: 7752480)
1. [Familial hyperparathyroidism].
Yamaguchi K; Kishikawa H; Shichiri M
Nihon Rinsho; 1995 Apr; 53(4):895-8. PubMed ID: 7752480
[TBL] [Abstract][Full Text] [Related]
2. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
J Clin Endocrinol Metab; 2000 Apr; 85(4):1449-54. PubMed ID: 10770180
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid carcinoma in familial hyperparathyroidism.
Dinnen JS; Greenwoood RH; Jones JH; Walker DA; Williams ED
J Clin Pathol; 1977 Oct; 30(10):966-75. PubMed ID: 412876
[TBL] [Abstract][Full Text] [Related]
4. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome.
Jackson CE; Norum RA; Boyd SB; Talpos GB; Wilson SD; Taggart RT; Mallette LE
Surgery; 1990 Dec; 108(6):1006-12; discussion 1012-3. PubMed ID: 2123361
[TBL] [Abstract][Full Text] [Related]
5. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
6. Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps.
Fujikawa M; Okamura K; Sato K; Mizokami T; Tamaki K; Yanagida T; Fujishima M
Eur J Endocrinol; 1998 May; 138(5):557-61. PubMed ID: 9625369
[TBL] [Abstract][Full Text] [Related]
7. Ossifying fibroma of the mandible with primary hyperparathyroidism due to non-familial parathyroid adenoma.
Harimaya A; Tsubota H; Hoki K; Sato J; Kondo A; Yamada T; Seki N; Ikeda H; Himi T
J Laryngol Otol; 2007 Mar; 121(3):281-4. PubMed ID: 17134536
[TBL] [Abstract][Full Text] [Related]
8. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
9. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
10. [Familial and isolated primary hyperparathyroidism. Case report].
Campusano C; Oestreicher E; Arteaga E; León A
Rev Med Chil; 2001 Nov; 129(11):1311-4. PubMed ID: 11836884
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
[TBL] [Abstract][Full Text] [Related]
13. Familial primary hyperparathyroidism complicated with Wilms' tumor.
Kakinuma A; Morimoto I; Nakano Y; Fujimoto R; Ishida O; Okada Y; Inokuchi N; Fujihira T; Eto S
Intern Med; 1994 Feb; 33(2):123-6. PubMed ID: 7912571
[TBL] [Abstract][Full Text] [Related]
14. A family case report of parathyroid carcinoma associated with
Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
[TBL] [Abstract][Full Text] [Related]
15. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
[TBL] [Abstract][Full Text] [Related]
16. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
Arnold A
Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
[TBL] [Abstract][Full Text] [Related]
17. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1.
Brandi ML; Aurbach GD; Fitzpatrick LA; Quarto R; Spiegel AM; Bliziotes MM; Norton JA; Doppman JL; Marx SJ
N Engl J Med; 1986 May; 314(20):1287-93. PubMed ID: 2871488
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of primary and secondary hyperparathyroidism.
Dotzenrath C; Goretzki PE; Farnebo F; Teh BT; Weber G; Röher HD; Larsson C
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():105-7. PubMed ID: 8981014
[TBL] [Abstract][Full Text] [Related]
20. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
